MutualMind was an enterprise listening platform with engagement and publishing features and analytics, that is now discontinued after the company's acquisition in 2016.
$1,000
per month
UpToDate
Score8.6 out of 10
N/A
UpToDate from Wolters Kluwer supports clinician decisioning with instant access to drug information, patient data, diagnosis support, and shareable data for patient information.
N/A
Pricing
MutualMind (discontinued)
UpToDate
Editions & Modules
No answers on this topic
No answers on this topic
Offerings
Pricing Offerings
MutualMind (discontinued)
UpToDate
Free Trial
No
No
Free/Freemium Version
No
No
Premium Consulting/Integration Services
No
No
Entry-level Setup Fee
No setup fee
No setup fee
Additional Details
—
—
More Pricing Information
Features
MutualMind (discontinued)
UpToDate
Billing and Claims Management
Comparison of Billing and Claims Management features of MutualMind (discontinued) and UpToDate
Feature
MutualMind (discontinued)
-
Ratings
UpToDate
5.0
1 Ratings
40% below category average
Real-time eligibility verification
00 Ratings
5.01 Ratings
Claims management
00 Ratings
6.01 Ratings
Coding
00 Ratings
5.01 Ratings
Patient billing
00 Ratings
4.01 Ratings
Financial Reporting
00 Ratings
5.01 Ratings
Patient Scheduling
Comparison of Patient Scheduling features of MutualMind (discontinued) and UpToDate
Feature
MutualMind (discontinued)
-
Ratings
UpToDate
4.0
1 Ratings
63% below category average
Calendar interface
00 Ratings
4.01 Ratings
Medical Security and Privacy
Comparison of Medical Security and Privacy features of MutualMind (discontinued) and UpToDate
Feature
MutualMind (discontinued)
-
Ratings
UpToDate
2.3
1 Ratings
113% below category average
HIPAA compliance
00 Ratings
3.01 Ratings
Role-based permission levels
00 Ratings
1.01 Ratings
Data backups and redundancy
00 Ratings
3.01 Ratings
Workflow and Scale
Comparison of Workflow and Scale features of MutualMind (discontinued) and UpToDate
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
MutualMind gives us a view into the reach of social content we produce on behalf of our advertisers and the engagement that content generates with shoppers.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
MutualMind gauges sentiment around social conversations but does so with the standard margin of error found in most social analytics products. The nature of human conversation makes it difficult for a machine to categorize sentiment with 100% accuracy. MutualMind gets sentiment right between 50% to 70% which is within acceptable industry averages for this type of product. With additional tuning (which MutualMind provides) the accuracy levels will increase.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
As a company that's only 3 years old, MutualMind's toolset is quite usable but it could use some tweaks in the user interface, which they are constantly working on.
During a recent upgrade period, MutualMind had a small window of unavailability. I am confident they have addressed the root cause and do not foresee any future issues.
The product's performance has improved greatly in the last year and we anticipate seeing additional improvements in coming months based no planned infrastructure changes.
UpToDate provides evidence-based, currently relevant medical information in an easy and clear method. The software has directly helped me stay up to date in medical treatments and new information on etiology of diseases. This information has directly and positively improved my care and treatments for various musculoskeletal conditions and diseases.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
UpToDate offers a much more comprehensive tool when compared with Epocrates. Although both provide good drug references UpToDate goes far beyond the Epocrates tool in terms of clinical disease diagnostic data.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
By showing increases in engagement and share of voice (defined as the amount of content generated for our advertisers versus the amount of content generated for their competitors over time) we are able to correlate content to incremental sales data provided by our advertisers.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info